NCT01002963 - A Study To Investigate The Safety And Toleration Of A Single Dose Of PF-04418948 In Healthy Volunteers | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

September 30, 2009

Primary Completion Date

February 28, 2010

Study Completion Date

February 28, 2010

Conditions

Healthy

Interventions

DRUG

PF-04418948

solution, 30 mg, single

DRUG

PF-04418948

solution, 100 mg, single

DRUG

PF-04418948

solution, 300 mg, single

DRUG

PF-04418948

solution, 1000 mg, single

DRUG

PF-04418948

solution, 3000 mg, single

DRUG

PF-04418948

solution, 4500 mg, single

DRUG

PF-04418948

solution, 6000 mg, single

Trial Locations (1)

Pfizer Investigational Site, Brussels